Press release
Epigenetics Market to grow USD 4.1 billion in 2030 | Abcam Plc., Zymo Research, Illumina Inc., Agilent Technologies, Inc., Active Motif
Download Sample PDF at: https://www.alliedmarketresearch.com/request-sample/846
Research and Development: Both academic and industrial research in the field of epigenetics have intensified. Pharmaceutical and biotechnology companies are investing heavily in developing epigenetic-based therapies and diagnostics for various diseases.
Cancer Diagnostics and Therapeutics: Epigenetic modifications play a crucial role in cancer development and progression. As a result, there has been considerable interest in developing epigenetic-based diagnostic tools and targeted therapies for cancer treatment.
Personalized Medicine: Epigenetic profiling has the potential to enable personalized medicine approaches. By understanding an individual's epigenetic profile, clinicians can better tailor treatments to the patient's specific needs.
Non-Invasive Biomarkers: Epigenetic markers have shown promise as non-invasive biomarkers for disease detection and monitoring. This has led to the exploration of liquid biopsies for cancer and other diseases.
Challenges: Despite the promising potential, the epigenetics market faces challenges such as complex regulatory landscapes, technical limitations, and ethical considerations related to data privacy and patient consent.
Market Drivers:
Rising Prevalence of Chronic Diseases: The increasing incidence of chronic diseases such as cancer, cardiovascular diseases, diabetes, and neurological disorders has driven the demand for novel diagnostic and therapeutic approaches. Epigenetic modifications play a critical role in the development and progression of these diseases, making epigenetics an attractive area of research for potential disease management strategies.
Advancements in Technology: Technological advancements in high-throughput sequencing, next-generation sequencing (NGS), and other epigenetic research tools have significantly improved the efficiency and affordability of studying epigenetic mechanisms. These technological breakthroughs have accelerated research in the field and fostered the development of innovative products and services.
Market Segmentation:
By Application:
a. Oncology: Epigenetics plays a crucial role in cancer development, and therefore, the oncology segment is a significant driver of the epigenetics market. It includes the use of epigenetic modifications for cancer diagnosis, prognosis, and treatment.
b. Non-Oncology: This segment encompasses epigenetic applications in various non-cancerous diseases, such as neurological disorders, cardiovascular diseases, metabolic disorders, autoimmune diseases, and more.
By Product:
a. Reagents and Kits: This segment includes various reagents, chemicals, and kits used in epigenetic research, such as DNA methylation kits, histone modification kits, and chromatin immunoprecipitation (ChIP) kits.
b. Instruments: It involves the different instruments used for epigenetic research, such as next-generation sequencers, mass spectrometers, PCR machines, and high-throughput screening systems.
c. Enzymes: This segment comprises enzymes involved in epigenetic modifications, such as DNA methyltransferases and histone deacetylases (HDACs).
By Technology:
a. DNA Methylation: This segment involves the study of DNA methylation patterns and their role in gene expression regulation.
b. Histone Modification: It includes the analysis of various histone modifications, such as acetylation, methylation, phosphorylation, and more.
c. Chromatin Remodeling: This segment focuses on the study of chromatin structure and its modification to influence gene expression.
d. RNA-Associated Epigenetics: It involves the study of non-coding RNAs, such as microRNAs and long non-coding RNAs, and their epigenetic regulatory roles.
By End-users:
a. Academic and Research Institutes: This segment includes universities, research institutions, and laboratories conducting basic and applied epigenetic research.
b. Pharmaceutical and Biotechnology Companies: It involves biopharmaceutical companies using epigenetics in drug discovery and development for various diseases.
c. Contract Research Organizations (CROs): CROs provide epigenetic research services to other organizations and play a significant role in the market.
Request for Customization - https://www.alliedmarketresearch.com/request-for-customization/846
Competitive Landscape:
Abcam Plc.
PerkinElmer, Inc.
Zymo Research
QIAGEN N.V.
Merck Millipore
Agilent Technologies, Inc.
Illumina Inc.
Active Motif, Inc.
Hologic Inc.
Thermo Fisher Scientific Inc.
Buy this Premium Research Report: https://www.alliedmarketresearch.com/purchase-enquiry/846
VALUE PROPOSITIONS RELATED TO THE REPORT:
Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
Comprehensive quantitative and qualitative insights at segment and sub-segment level
Covid 19 impact trends and perspective
Granular insights at global/regional/country level
Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment.
Related Reports :
Breast Cancer Drugs Market https://www.alliedmarketresearch.com/breast-cancer-drugs-market-A11123
Surgical Microscopes Market https://www.alliedmarketresearch.com/surgical-operating-microscopes-market
Fluid Management Devices Market https://www.alliedmarketresearch.com/fluid-management-devices-market
Cord Blood Banking Services Market https://www.alliedmarketresearch.com/cord-blood-banking-services-market
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Epigenetics Market to grow USD 4.1 billion in 2030 | Abcam Plc., Zymo Research, Illumina Inc., Agilent Technologies, Inc., Active Motif here
News-ID: 3170641 • Views: …
More Releases from Allied Market Research
Global Urinary Drainage Bags Market: Trends, Growth, and Insights to 2031
The global urinary drainage bags market is experiencing robust growth, with its market size valued at $1.4billion in 2021 and projected to reach $2billion by 2031. This expansion represents a compound annual growth rate (CAGR) of 3.8% from 2021 to 2031, highlighting the increasing demand for these essential medical devices.
Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/A17529
What Are Urinary Drainage Bags?
Urinary drainage bags are specialized medical devices designed to collect…
Cream Powder Market to Reach $8.9 Billion by 2031 with 6.4% CAGR
The global cream powder industry was estimated at $4.8 billion in 2021 and is expected to hit $8.9 billion by 2031, registering a CAGR of 6.4% from 2022 to 2031.
The cream powder market is experiencing growth due to various factors, including the increasing popularity of bakeries and HoReCa (hotels, restaurants, and cafes) and rising consumer demand for natural products. The dairy-based segment is a significant contributor to the market's growth…
Micro Drone Market Valued at $6.71 Billion in 2020, Expected to Reach $28.91 Bil …
The global micro drone industry generated $6.71 billion in 2020, and is expected to reach $28.91 billion in 2030, witnessing a CAGR of 17.2% from 2021 to 2030. The report provides an extensive analysis of changing market dynamics, top segments, top investment pockets, regional landscape, value chain, and competitive scenario.
Increased operational efficiency and rise in demand for improved surveillance drive the growth of the global micro drone market. However, strict…
Microwavable Foods Market to reach $230.93 billion by 2031, growing at a CAGR of …
The global microwaveable foods industry was accounted for $120.45 billion in 2020, and is expected to reach $230.93 billion by 2031, growing at a CAGR of 5.6% from 2022 to 2031.
Rise in popularity of fast-food restaurants and large population base coupled with increase in number of quick-service restaurants drive the global microwaveable foods market. However, lack of awareness about microwavable foods hinders the market growth. On the contrary, rise in…
More Releases for Epigenetic
Epigenetics Market - Harnessing the Epigenetic Revolution: Transforming the Futu …
Newark, New Castle, USA - The latest report from Growth Plus Reports analyzes the production, potential applications, demand, major manufacturers, and SWOT analysis of the global Epigenetics Market.
Epigenetics Market: https://www.growthplusreports.com/report/epigenetics-market/9171
The Epigenetics Market Report assists in determining the optimum distribution methods for certain products as well as possible markets for future product launches. The report also analyses the purchase and supply trends that influence the market's production strategy. The Epigenetics market…
Epigenetic Market 2021 | Detailed Report
The Epigenetic research report undoubtedly meets the strategic and specific needs of the businesses and companies. The report acts as a perfect window that provides an explanation of market classification, market definition, applications, market trends, and engagement. The competitive landscape is studied here in terms of product range, strategies, and prospects of the market’s key players. Furthermore, the report offers insightful market data and information about the Epigenetic industry to…
Epigenetic Market major players New England Biolabs, Inc., Thermo Fisher Scienti …
Epigenetic procedure involves stable changes in genome, which are reversible in gene expression. These changes can be transferred generation to generation, but contains no permanent changes in DNA. The epigenetically controlled genes are repressed or activated with no genotypic change in DNA. Epigenetic changes occur phenotypically but will have no genotypic change in the gene. This changes can occur naturally but can also be initiated by the environment changes, aging,…
Epigenetic Market Forecast By End-use Industry 2016-2026
Epigenetic procedure involves stable changes in genome, which are reversible in gene expression. These changes can be transferred generation to generation, but contains no permanent changes in DNA. The epigenetically controlled genes are repressed or activated with no genotypic change in DNA. Epigenetic changes occur phenotypically but will have no genotypic change in the gene. This changes can occur naturally but can also be initiated by the environment changes, aging,…
Epigenetic Market to Observe Strong Development by 2016-2026
The epigenetic process includes phosphorylation, methylation, sumolyation, acetylation and ubiquitylation etc. of DNA as well as histones resulting in changes in Phenotypes. These changes are modified with environmental conditions. Epigenetic market is now an emerging field. There are various diagnostic tests available now that detect epigenetic changes. There are some FDA approved epigenetic drugs. Other than many diagnostic companies, many biopharmaceutical and pharmaceutical companies are also very active in the…
Epigenetic Market Plying for Significant Growth During 2016-2026
Epigenetic procedure involves stable changes in genome, which are reversible in gene expression. These changes can be transferred generation to generation, but contains no permanent changes in DNA. The epigenetically controlled genes are repressed or activated with no genotypic change in DNA. Epigenetic changes occur phenotypically but will have no genotypic change in the gene. This changes can occur naturally but can also be initiated by the environment changes, aging,…
